Due 0 3 0 3 O
to 4 6 4 6 O
unknown 7 14 7 14 O
effects 15 22 15 22 O
of 23 25 23 25 O
this 26 30 26 30 O
therapy 31 38 31 38 B-treatment
on 39 41 39 41 O
a 42 43 42 43 O
fetus 44 49 44 49 O
, 49 50 49 50 O
pregnant 51 59 51 59 B-pregnancy
women 60 65 60 65 B-gender
are 66 69 66 69 O
excluded 70 78 70 78 O
from 79 83 79 83 O
this 84 88 84 88 O
research 89 97 89 97 O
. 97 98 97 98 O
The 99 102 99 102 O
male 103 107 103 107 B-gender
partner 108 115 108 115 O
should 116 122 116 122 O
use 123 126 123 126 B-contraception_consent
a 127 128 127 128 I-contraception_consent
condom 129 135 129 135 I-contraception_consent
. 135 136 135 136 O
Females 137 144 137 144 B-gender
of 145 147 145 147 O
child 148 153 148 153 O
- 153 154 153 154 O
bearing 154 161 154 161 O
potential 162 171 162 171 O
must 172 176 172 176 O
be 177 179 177 179 O
willing 180 187 180 187 B-contraception_consent
to 188 190 188 190 I-contraception_consent
utilize 191 198 191 198 I-contraception_consent
one 199 202 199 202 I-contraception_consent
of 203 205 203 205 I-contraception_consent
the 206 209 206 209 I-contraception_consent
more 210 214 210 214 I-contraception_consent
effective 215 224 215 224 I-contraception_consent
birth 225 230 225 230 I-contraception_consent
control 231 238 231 238 I-contraception_consent
methods 239 246 239 246 I-contraception_consent
during 247 253 247 253 O
the 254 257 254 257 O
study 258 263 258 263 O
unless 264 270 264 270 O
female 271 277 271 277 B-gender
has 278 281 278 281 O
had 282 285 282 285 O
a 286 287 286 287 O
hysterectomy 288 300 288 300 B-contraception_consent
or 301 303 301 303 O
tubal 304 309 304 309 B-contraception_consent
ligation 310 318 310 318 I-contraception_consent

Engrafted 0 9 319 328 B-treatment
post 10 14 329 333 I-treatment
transplant 15 25 334 344 I-treatment
( 26 27 345 346 O
ANC 27 30 346 349 B-clinical_variable
> 31 32 350 351 O
500 32 35 351 354 B-lower_bound
) 35 36 354 355 O
and 37 40 356 359 O
ANC 41 44 360 363 O
> 45 46 364 365 O
500 46 49 365 368 O
at 50 52 369 371 O
the 53 56 372 375 O
time 57 61 376 380 O
of 62 64 381 383 O
infusion 65 73 384 392 B-treatment

Hgb 0 3 393 396 B-clinical_variable
greater 4 11 397 404 O
than 12 16 405 409 O
or 17 19 410 412 O
equal 20 25 413 418 O
to 26 28 419 421 O
7.0 29 32 422 425 B-lower_bound
( 33 34 426 427 O
transfusions 34 46 427 439 O
allowed 47 54 440 447 O
) 54 55 447 448 O

If 0 2 449 451 O
patient 3 10 452 459 O
has 11 14 460 463 O
received 15 23 464 472 O
an 24 26 473 475 O
autologous 27 37 476 486 B-treatment
or 38 40 487 489 O
syngeneic 41 50 490 499 B-treatment
SCT 51 54 500 503 I-treatment
they 55 59 504 508 O
must 60 64 509 513 O
be 65 67 514 516 O
> 68 69 517 518 O
90 69 71 518 520 B-lower_bound
days 72 76 521 525 I-lower_bound
post 77 81 526 530 B-treatment
- 81 82 530 531 I-treatment
transplant 82 92 531 541 I-treatment
( 93 94 542 543 O
Group 94 99 543 548 O
A 100 101 549 550 O
) 101 102 550 551 O

Patients 0 8 552 560 O
receiving 9 18 561 570 O
systemic 19 27 571 579 B-treatment
corticosteroid 28 42 580 594 I-treatment
within 43 49 595 601 O
48 50 52 602 604 B-upper_bound
hours 53 58 605 610 I-upper_bound
of 59 61 611 613 O
CTL 62 65 614 617 B-treatment
infusion 66 74 618 626 I-treatment

Patients 0 8 627 635 O
should 9 15 636 642 O
have 16 20 643 647 O
been 21 25 648 652 O
off 26 29 653 656 O
conventional 30 42 657 669 B-treatment
therapy 43 50 670 677 I-treatment
for 51 54 678 681 O
at 55 57 682 684 O
least 58 63 685 690 O
48 64 66 691 693 B-lower_bound
hours 67 72 694 699 I-lower_bound
prior 73 78 700 705 I-lower_bound
to 79 81 706 708 O
entry 82 87 709 714 O
in 88 90 715 717 O
this 91 95 718 722 O
study 96 101 723 728 O
( 102 103 729 730 O
except 103 109 730 736 O
for 110 113 737 740 O
lenalidomide 114 126 741 753 B-treatment
, 126 127 753 754 O
thalidomide 128 139 755 766 B-treatment
, 139 140 766 767 O
pomalidomide 141 153 768 780 B-treatment
or 154 156 781 783 O
immune 157 163 784 790 O
checkpoint 164 174 791 801 B-treatment
inhibitors 175 185 802 812 I-treatment
such 186 190 813 817 O
as 191 193 818 820 O
CTLA4 194 199 821 826 B-treatment
and/or 200 206 827 833 O
PD-1 207 211 834 838 B-treatment
/ 211 212 838 839 O
PD 212 214 839 841 B-treatment
- 214 215 841 842 I-treatment
L1 215 217 842 844 I-treatment
inhibitors 218 228 845 855 I-treatment
) 228 229 855 856 O

Patients 0 8 857 865 O
should 9 15 866 872 O
have 16 20 873 877 O
been 21 25 878 882 O
off 26 29 883 886 O
other 30 35 887 892 O
investigational 36 51 893 908 B-treatment
therapy 52 59 909 916 I-treatment
for 60 63 917 920 O
one 64 67 921 924 B-upper_bound
month 68 73 925 930 I-upper_bound
prior 74 79 931 936 I-upper_bound
to 80 82 937 939 O
entry 83 88 940 945 O
in 89 91 946 948 O
this 92 96 949 953 O
study 97 102 954 959 O

Patients 0 8 960 968 O
with 9 13 969 973 O
a 14 15 974 975 O
Karnofsky 16 25 976 985 B-clinical_variable
score 26 31 986 991 I-clinical_variable
of 32 34 992 994 O
greater 35 42 995 1002 O
than 43 47 1003 1007 O
or 48 50 1008 1010 O
equal 51 56 1011 1016 O
to 57 59 1017 1019 O
50 60 62 1020 1022 B-lower_bound

Patients 0 8 1023 1031 O
with 9 13 1032 1036 O
a 14 15 1037 1038 O
creatinine 16 26 1039 1049 B-clinical_variable
less 27 31 1050 1054 O
than 32 36 1055 1059 O
or 37 39 1060 1062 O
equal 40 45 1063 1068 O
to 46 48 1069 1071 O
2x 49 51 1072 1074 B-upper_bound
upper 52 57 1075 1080 I-upper_bound
limit 58 63 1081 1086 I-upper_bound
of 64 66 1087 1089 I-upper_bound
normal 67 73 1090 1096 I-upper_bound
for 74 77 1097 1100 O
age 78 81 1101 1104 B-age

Patients 0 8 1105 1113 O
with 9 13 1114 1118 O
active 14 20 1119 1125 O
HIV 21 24 1126 1129 B-chronic_disease
infection 25 34 1130 1139 I-chronic_disease
at 35 37 1140 1142 O
time 38 42 1143 1147 O
of 43 45 1148 1150 O
procurement 46 57 1151 1162 O
( 58 59 1163 1164 O
can 59 62 1164 1167 O
be 63 65 1168 1170 O
pending 66 73 1171 1178 O
at 74 76 1179 1181 O
the 77 80 1182 1185 O
time 81 85 1186 1190 O
of 86 88 1191 1193 O
blood 89 94 1194 1199 O
draw 95 99 1200 1204 O
) 99 100 1204 1205 O

Patients 0 8 1206 1214 O
with 9 13 1215 1219 O
bilirubin 14 23 1220 1229 B-clinical_variable
less 24 28 1230 1234 O
than 29 33 1235 1239 O
or 34 36 1240 1242 O
equal 37 42 1243 1248 O
to 43 45 1249 1251 O
2 46 47 1252 1253 B-upper_bound
times 48 53 1254 1259 I-upper_bound
upper 54 59 1260 1265 I-upper_bound
limit 60 65 1266 1271 I-upper_bound
of 66 68 1272 1274 I-upper_bound
normal 69 75 1275 1281 I-upper_bound
, 75 76 1281 1282 O
AST 77 80 1283 1286 B-clinical_variable
less 81 85 1287 1291 O
than 86 90 1292 1296 O
or 91 93 1297 1299 O
equal 94 99 1300 1305 O
to 100 102 1306 1308 O
3 103 104 1309 1310 B-upper_bound
times 105 110 1311 1316 I-upper_bound
upper 111 116 1317 1322 I-upper_bound
limit 117 122 1323 1328 I-upper_bound
of 123 125 1329 1331 I-upper_bound
normal 126 132 1332 1338 I-upper_bound
, 132 133 1338 1339 O
and 134 137 1340 1343 O
Hgb 138 141 1344 1347 B-clinical_variable
greater 142 149 1348 1355 O
than 150 154 1356 1360 O
or 155 157 1361 1363 O
equal 158 163 1364 1369 O
to 164 166 1370 1372 O
7.0 167 170 1373 1376 B-lower_bound
( 171 172 1377 1378 O
transfusion 172 183 1378 1389 B-treatment
allowed 184 191 1390 1397 O
) 191 192 1397 1398 O

Patients 0 8 1399 1407 O
with 9 13 1408 1412 O
severe 14 20 1413 1419 O
active 21 27 1420 1426 B-chronic_disease
infection 28 37 1427 1436 I-chronic_disease

Pregnant 0 8 1437 1445 B-pregnancy

Pulse 0 5 1446 1451 B-clinical_variable
oximetry 6 14 1452 1460 I-clinical_variable
of 15 17 1461 1463 O
> 18 19 1464 1465 O
93 19 21 1465 1467 B-lower_bound
% 21 22 1467 1468 I-lower_bound
on 23 25 1469 1471 O
room 26 30 1472 1476 O
air 31 34 1477 1480 O
in 35 37 1481 1483 O
patients 38 46 1484 1492 O
who 47 50 1493 1496 O
previously 51 61 1497 1507 O
received 62 70 1508 1516 O
radiation 71 80 1517 1526 B-treatment
therapy 81 88 1527 1534 I-treatment

